Endoplasmic reticulum targeting liposomes
作者： Raymond Allen Dwek , Nicole Zitzmann , Stephanie Pollock
DOI:
关键词:
摘要: Provided are compositions that include lipid particles, such as liposomes, can fuse with the ER membrane of a cell. The particles also deliver cargo, therapeutic or an imaging agent, encapsulated inside lumen be useful for treating and/or preventing diseases conditions caused by associated virus, viral infections, including HIV and HCV infections.
google.nl 参考文章(70)
Larry R. Rohrschneider, Everett J. Nichols, Therapy using glucosidase processing inhibitors ,(1985)
Mike G. Scaros, Rick J. Rutter, Bryan H. Landis, Roy W. Grabner, Process for producing n-substituted polyhydroxy nitrogen-containing heterocycles utilizing acetobacteraceae and corynebacterium ,(1992)
Peter Tijssen, Jan van den Hurk, Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53) ,(1995)
Dominique Dugourd, Combination anti-viral compositions and methods of use ,(2005)
Slobodan Tepic, Anti-viral therapeutic composition ,(1987)
Michael Schedel, Wolfgang Koebernick, Gunther Kinast, Production of N-substituted derivatives of 1-desoxynojirimicin ,(1981)
Sara L. Krause-Elsmore, Raphael J. Mannino, Rigid liposomal cochleate and methods of use and manufacture ,(2004)
James R. Behling, George W. J. Fleet, John R. Medich, Kevin A. Babiak, Synthesis of 1,4-dideoxy-1,4-imino-L-arabinitol ,(1993)
Paul W. Glue, Janice K. Albrecht, Ribavirin-pegylated interferon alfa induction hcv combination therapy ,(1999)
Paul Tardi, Ludger M. Ickenstein, Lawrence D. Mayer, Murray Webb, Lipid carrier compositions with enhanced blood stability ,(2002)